Arkolith/Insider Trading/JAZZ/Form 4

Winningham Rick E

DirectorJazz Pharmaceuticals plc (JAZZ) · full profile →Form 4 · filed May 27, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$662K
Net Open-Market Flow
-$662K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 22, 2026Option exercise(M)3K$138.08$472K12K
May 22, 2026Sell(S)3K$241.57$662K10K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 22, 2026Option exercise(M)3K—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001302443-26-000008) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML